← Back to Search

Patients with Gastric Cancer (Training) for Gastric Cancer (DESTINEX Trial)

N/A
Recruiting
Led By Ajay Goel, PhD
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

DESTINEX Trial Summary

Gastric cancer continues to have a poor prognosis primarily due to the inability to detect it in its early stages. This study will develop and validate a blood assay to facilitate the non-invasive detection of gastric cancer.

Eligible Conditions
  • Gastric Cancer
  • Gastric Neoplasm
  • Stomach Cancer
  • Gastric Ulcer

DESTINEX Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity
Secondary outcome measures
Proportion of correct predictions (true positives and true negatives) among the total cases (i.e., accuracy)
Specificity

DESTINEX Trial Design

4Treatment groups
Experimental Treatment
Group I: Patients without Gastric Cancer (Validation)Experimental Treatment1 Intervention
Individuals without cancer at the time of blood sampling
Group II: Patients without Gastric Cancer (Training)Experimental Treatment1 Intervention
Individuals without cancer at the time of blood sampling
Group III: Patients with Gastric Cancer (Validation)Experimental Treatment1 Intervention
Individuals with a pathologically confirmed diagnosis of gastric cancer
Group IV: Patients with Gastric Cancer (Training)Experimental Treatment1 Intervention
Individuals with a pathologically confirmed diagnosis of gastric cancer

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,920,660 Total Patients Enrolled
Ajay Goel, PhDPrincipal InvestigatorCity of Hope Medical Center
6 Previous Clinical Trials
3,577 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
CA: A Cancer Journal for CliniciansJournal
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Sung, Hyuna, Jacques Ferlay, Rebecca L. Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, and Freddie Bray. 2021. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA: A Cancer Journal for Clinicians. Wiley. doi:10.3322/caac.21660.
clinicaltrials.govStudy
Stomach Cancer Exosome-based Detection
2023. "Stomach Cancer Exosome-based Detection". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06342427.
All > Anaheim > Paid Studies Ventura
~333 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top